期刊文献+

血管紧张素(1-7)对不同模型高血压大鼠左心室结构的影响 被引量:3

Effect of angiotensin( 1 -7) on left ventricular hypertrophy and myocardial fibrosis in 2K1C and INAC hypertensive models
下载PDF
导出
摘要 目的探讨血管紧张素(1-7)[Ang(1-7)]对单纯压力负荷增加及肾素-血管紧张素-醛固酮系统(RAAS)激活的高血压模型左心室肥厚及心肌纤维化的影响及其机制。方法建立二肾一夹(2K1C)及肾下主动脉缩窄(INAC)模型,应用微渗泵植入技术,使Ang(1-7)进行不同时间(14、28d)的体内干预,采用定性及定量分析的方法检测Ang(1-7)对这2种高血压模型早期(14d)和晚期(42d)左心室心肌细胞及纤维化程度的影响。结果对2K1C和INAC动物模型,早期其左心室质量(LVW)、左心室质量指数(LVI)及左心室心肌细胞横断面积(LCA)均较对照组明显增加(P<0.05),晚期上述指标增加更为显著(P<0.01);Ang(1-7)可使2K1C动物模型的上述指标均显著下降(P<0.05),但对INAC动物模型,Ang(1-7)使其上述指标在早期显著下降(P<0.05),晚期略有下降(P>0.05)。对2K1C动物模型,早期已出现明显的心肌纤维化(P<0.05),晚期更为显著(P<0.01);Ang(1-7)可明显抑制早期的间质及血管周围纤维化(P<0.05),在晚期,Ang(1-7)可明显抑制血管周围纤维化(P<0.05),但对间质纤维化,虽有下降趋势,但不明显(P>0.05)。对IN-AC动物模型,早期心肌纤维化并不显著(P>0.05),晚期则有明显表现(P<0.05),Ang(1-7)可有效抑制间质和血管周围纤维化(P<0.05)。结论Ang(1-7)可预防改善这2种高血压模型的左心室肥厚和心肌纤维化,但对2种模型不同时期的改善程度不同,提示Ang(1-7)可能具有不同的作用机制。 Obiective To determine the effect ofangiotensin(1-7) [Ang(1-7) J on the left ventricular hypertrophy and myocardial fibrosis in a pressure-overload hypertensive models, infra-nephrie aorta coarctation (INAC), and a renin-angiotensin-aldosterone system (RAAS) activation hypertensive model, two kidney one clip (2K1C) in the early and late stage. Methods Totally 120 health male Wistar rats were randomly and equally divided into 6 groups, that is, sham INAC group, INAC group, INAC Ang(1-7) group, sham 2KIC group, 2K1C group and 2K1C Ang( 1 -7) group. INAC and 2K1C hypertensive models was established to corresponding groups and osmotic minipump implantation was carried out to the rats to deliver the Ang( 1 -7 ) to their body homogenously and to examine the parameters representing the blood pressure, including left ventricular hypertrophy (LVW, LVI, CA) and myocardial fibrosis (CVF and PVCA). Results Left ventricular hypertrophy (LVH) was observed in the early stage and developed in the late stage both in the 2K1C and INAC groups. Ang( 1 -7) decreased LVW, LVI, CA both in the early and late stage in the 2K1C model(P 〈0. 05). But to INAC model, Ang ( 1 - 7 ) only decreased the pressures in the early stage (P 〈 0.05), but not in the late stage(P 〉 0. 05). Myocardial fibrosis happened and developed progressively in the 2K1C hypertensive model (P 〈 0. 05). Ang( 1 -7) was able to alleviate interstitial as well as perivascular fibrosis as used in the early stage (P 〈 0. 05 ), while it only alleviated perivascular fibrosis in the late stage ( P 〈 0. 05 ), had no marked effect on the interstitial fibrosis(P 〉0. 05). There was a mild myocardial fibrosis happened in the left ventricle of the INAC model in the late stage(P 〈0. 05), and Ang( 1-7) was able to alleviate both interstitial and perivaseular fibrosis effectively(P 〈 0. 05). Conclusion Ang (1 -7 ) can effectively prevent and improve left ventricular hypertrophy and myocardial fibrosis, but in the different stage, it exerts different effect, which indicate there are multiple mechanisms of Ang(1 -7) .
出处 《第三军医大学学报》 CAS CSCD 北大核心 2009年第18期1753-1756,共4页 Journal of Third Military Medical University
关键词 血管紧张素(1—7) 压力超负荷 肾素-血管紧张素-醛固酮系统 左心室肥厚 心肌纤维化 angiotensin ( 1 - 7 ) pressure overload hypertension renin-angiotensin-aldosterone system left ventricular hypertrophy myocardial fibrosis
  • 相关文献

参考文献11

  • 1Schindler C, Bramlage P, Kirch W, et al. Role of the vasodilator peptide angiotensin-( 1 - 7 ) in cardiovascular drug therapy [ J ]. Vasc Health and Risk Manag, 2007, 3( 1 ) : 125 -137.
  • 2Ferrario C M, Jessup J, Chappell M C, et al. Effect of angiotensinconverting enzyme inhibition and angiotensin Ⅱ receptor blockers on cardiac angiotensin-converting enzyme 2 [ J ]. Circulation, 2005, 111 (20) : 2605 -2610.
  • 3Iyer S N, Ferrario C M, Chappell M C. Angiotensin ( 1 - 7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system[ J]. Hypertension, 1998, 31 ( 1 Pt 2) : 356 - 361.
  • 4Wilsdorf T, Gainer J V, Murphey L J, et al. Angiotensin-( 1 - 7) does not affect vasodilator or TPA responses to bradykinin in human forearm [J]. Hypertension, 2001, 37(4): 1136-1140.
  • 5于学军,何作云,黄岚,王晓燕.血管紧张素(1-7)对两种模型高血压大鼠心功能的影响[J].心脏杂志,2008,20(6):668-672. 被引量:3
  • 6于学军,何作云,王晓燕.两种高血压大鼠模型心肌纤维化的动态变化及其与循环、心肌组织内肾素-血管紧张素系统和压力负荷之间的关系[J].中国微循环,2004,8(4):209-213. 被引量:5
  • 7Swynghedauw B. Molecular mechanisms of myocardial remodeling[ J]. Physiol Rev, 1999, 79( 1 ) : 215 -262.
  • 8田颖,祝善俊,王江,李为民,孔一慧.BRL37344对心衰大鼠血液TNF-α、AngⅡ、ET-1含量及心肌重构的影响[J].第三军医大学学报,2005,27(19):1939-1942. 被引量:4
  • 9Keidar S, Kaplan M, Gamliel-Lazarovich A. ACE2 of the heart : From angiotensin Ⅰ to angiotensin ( 1 - 7) [ J]. Cardiovasc Res, 2007, 73 (3) : 463 - 469.
  • 10Grobe J L, Mecca A P, Lingis M, et al. Prevention of angiotensin Ⅱ- induced cardiac remodeling by angiotensin-( 1 -7) [ J ]. Am J Physiol Heart Circ Physiol, 2007, 292(2) : H736 - H742.

二级参考文献30

  • 1Lopez B,Gonzalez A,Varo N,et al.Biochemical assessment of myocardial fibrosis in hypertensive heart disease[J].Hypertension.2001,38(5):1222~1226
  • 2Morishita R,Aoki M,Ogihara T.Functional analysis of cardiovascular renin-angiotensin system using a gain or loss of function approach[J].Hypertens Res,2000,23(2):137~141
  • 3Guan S,Fox J,Mitchel KD.Angiotensin and angiotensin converting enzyme tissue levels in two kidney one clip hypertensive rats[J].Hypertension.1992,20:763~767
  • 4Sun Y,Cleutjens JPM,Diaz Arias AA,et al.Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat[J].Cardiovasc Res.1994,28:1423~1432
  • 5Swynghedauw B.Molecular Mechanisms of myocardial remodeling[J].Physiological Rev.1999,79( 1 ):219~262
  • 6Schindler C, Bramlage P, Kirch W, et al. Role of the vasodilator peptide angiotensin-( 1 - 7 ) in cardiovascular drug therapy[ J ]. Vasc Health Risk Manag, 2007, 3 ( 1 ) : 125 - 137.
  • 7Tallant EA, Diz DI, Ferrario CM. Antiproliferative actions of angiotensin-( 1 - 7 ) in vascular smooth muscle [ J ]. Hypertension, 1999, 34(4 Pt 2) :950 -957.
  • 8Ferrario CM, Jessup J, Chappell MC, et al. Effect of angiotensinconvertingenzyme inhibition and angiotensin Ⅱ receptor blockers on cardiac angiotensin-converting enzyme 2[J]. Circulation, 2005, 111 (20) :2605 -2610.
  • 9Iyer SN, Ferrario CM, Chappell MC. Angiotensin ( 1 - 7) contributes to the antihypertensive effects of blockade of the rennin-angiotensin system[J].Hypertension, 1998, 31 ( 1 Pt 2) :356 -361.
  • 10Wilsdorf T, Gainer JV, Murphey LJ, et al. Angiotensin-( 1 - 7 ) does not affect vasodilator or TPA responses to bradykinin in human forearm [ J ]. Hypertension, 2001 , 37 (4) : 1136 - 1140.

共引文献8

同被引文献33

  • 1Dilauro M, Burns KD. Angiotensin -(1-7 )and its effects in the kidney[J].Scientific World J, 2009, 9: 522-535.
  • 2Munoz MC, Giani JF, Dominiei FP. Angiotensin-(1-7)stimu- lates the phosphorylation of Akt in rat extraeardiae tissues in vivo via receptor Mas[J]. Regul Pept 2010, 161:1-7.
  • 3Tallant EA, McCollum LT, Gallagher PE. Angiotensin-(1-7) reduces Ang II-induced cardiac hypertrophy with an associated increase in the dualspecificity phosphatase 1 (DUSP1) [abstract] [J]. Hypertension 2009,54:e122.
  • 4Gallagher PE, Tallant EA. Angiotensin -( l -7 )reduces MAP kinase activity by upregulation of the dual-specificity phos- phatase DUSP1 [abstract] [J]. Hypertension 2009,54:e35.
  • 5Pendergrass KD, Pirro NT, Westwood BM, et al. Sex differ- ences in circulating and renal angiotensins of hypertensive mRen (2).Lewis but not normotensive Lewis rats[J]. Am J Physiol Heart Circ Physiol 2008,295:H10 - H20.
  • 6Koitka A, Cooper ME, Thomas MC, Tikellis C. Angiotensin converting enzyme 2 in the kidney[J].Clin Exp Pharmacol Physiol 2008,35:420-425.
  • 7Chen J, Gu D, Huang J, et al. Metabolic syndrome and sah sensitivity of blood pressure in nondiabetic people in China: a di- etaly intervention study[J]. Lancet 2009,373:829 - 835.
  • 8Audo K, Fujita M. Reactive oxygen species and the central nervous system in salt-sensitive hypertension: possible relation- ship to obesity-induced hypertension [J].Clin Exp Pharmacol Physiol. 2012,39:111-116.
  • 9Gurley SB, Riquier-Brison AD, Schnermann J, et al. ATIA angiotensin receptors in the renal proximal tubule regulate blood pressure[J]. Cell Metab. 2011,13:469-475.
  • 10Shibata S, Mu SY, Kawarazaki H, et al. Racl GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptordependent pathway [J].J Clin Invest. 2011,121:3233-3243.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部